Literature DB >> 2282634

Neuroleptic malignant syndrome with intravenous haloperidol.

A J Levitt, R Midha, J L Craven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2282634     DOI： 10.1177/070674379003500914

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  2 in total

1.  Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca(2+) release channel.

Authors:  D Cavagna; F Zorzato; E Babini; G Prestipino; S Treves
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia.

Authors:  Minfeng Cheng; Huaying Gu; Liangrong Zheng; Houliang Wang; Zhiyong Zhong; Shenglin Wen
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-29       Impact factor: 2.570
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.